Mary Anna Venneri

Publications

Title Published on Year
Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial THE LANCET DIABETES & ENDOCRINOLOGY 2018
Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply THE LANCET DIABETES & ENDOCRINOLOGY 2018
Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas EUROPEAN JOURNAL OF ENDOCRINOLOGY 2018
Chronic phosphodiesterase type 5 inhibition has beneficial effects on subcutaneous adipose tissue plasticity in type 2 diabetic mice JOURNAL OF CELLULAR PHYSIOLOGY 2018
Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a dream trial ancillary study THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2018
Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role? FRONTIERS IN ENDOCRINOLOGY 2018
Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7 SCIENTIFIC REPORTS 2017
PDE5 inhibition ameliorates visceral adiposity targeting the miR-22/SIRT1 pathway: evidence from the CECSID trial THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2016
Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2016
Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury CELL DEATH & DISEASE 2016
Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice PLOS ONE 2015
Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask). how do they work JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2015
Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes EXPERT OPINION ON THERAPEUTIC TARGETS 2015

ERC

  • LS4
  • LS4_4
  • LS4_9

Interessi di ricerca

Keywords

acute and chronic inflammation diseases
diabetes and metabolism
endocrine disorders

Gruppi di ricerca

Circadian rhythms and neuro-immuno-endocrinology
Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante

Gruppi di ricerca - Responsabile

Adipose tissue remodeling
Circadian Regulation of Immune cells

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma